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Abstract
The rodent parasite  is an important  model ofPlasmodium chabaudi in vivo 
malaria. The ability to produce chronic infections makes it particularly useful
for investigating the development of anti-  immunity, as well asPlasmodium
features associated with parasite virulence during both the acute and
chronic phases of infection.   also undergoes asexualP. chabaudi
maturation (schizogony) and erythrocyte invasion in culture, so offers an
experimentally-amenable  to model for studying gene functionin vivo  in vitro 
and drug activity during parasite replication. To extend the usefulness of
this model, we have further optimised transfection protocols and plasmids
for   and generated stable, fluorescent lines that are free fromP. chabaudi
drug-selectable marker genes. These mother-lines show the same infection
dynamics as wild-type parasites throughout the lifecycle in mice and
mosquitoes; furthermore, their virulence can be increased by serial blood
passage and reset by mosquito transmission. We have also adapted the
large-insert, linear  GEM vectors that have revolutionised the scalePlasmo
of experimental genetics in another rodent malaria parasite and used these
to generate barcoded  gene-deletion and –tagging vectors forP. chabaudi 
transfection in our fluorescent   mother-lines. This produces aP. chabaudi
tool-kit of  lines, vectors and transfection approaches that willP. chabaudi 
be of broad utility to the research community.
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Introduction
The rodent parasite Plasmodium chabaudi is a leading in vivo 
model for the study of host immunity and immunopathology in 
malaria, and provides an extremely powerful tool to study the 
parasite biology and parasite-host interactions that underpin 
virulence, chronicity and transmission (Spence et al., 2013; 
Spence et al., 2015). This is because P. chabaudi demonstrates 
sequestration and rosetting at the mature schizont stage and 
resolves to establish a chronic infection with periodic recru-
descence and antigenic variation, in a similar manner to the 
dominant cause of human malaria mortality, P. falciparum 
(reviewed in (Langhorne et al., 2002; Stevenson & Riley 2004)). 
Furthermore, commitment to sexual development (gametocy-
togenesis) increases after the resolution of acute infection and 
development in the mosquito progresses through each bottleneck 
with physiologically relevant parasite numbers (Spence et al., 
2012). In addition, there are a large number of phenotypically 
diverse parasite genotypes available, which provide a unique 
opportunity to a) develop co-infection, superinfection and 
re-infection models and b) interrogate the role of parasite 
genetics in shaping the course and outcome of infection. 
Plasmodium chabaudi is therefore an extremely adaptable model 
that can be used to study every step in the Plasmodium life 
cycle.
Despite the phenotypic advantages of this model system, the 
development of transfection technologies for P. chabaudi 
has lagged behind those for other rodent malaria models. 
Methods for generating Plasmodium chabaudi reporter lines by 
single cross-over recombination and genomic integration of a 
fluorescent or luminescent protein cassette have, however, 
been described (Brugat et al., 2014; Reece & Thompson 2008; 
Spence et al., 2011), and these parasites and transfection 
methods have proved useful for imaging parasite accu-
mulation and associated pathology in host tissues (Brugat 
et al., 2014; Borges da Silva et al., 2015; Brugat et al., 2017; 
Cunningham et al., 2017; Medeiros et al., 2013), as well as 
for visualising parasite protein localisation (Yam et al., 2016). 
Nevertheless, the relative inefficiency of these techniques has 
hindered the progress of P. chabaudi experimental genetic 
studies.
To improve the accessibility and reproducibility of P. chabaudi 
transfection techniques, we have optimised methods that enable 
parasite purification and transfection in the laboratory and drug 
selection in wild-type mice, and have used these methods to 
generate stable, highly-fluorescent lines by double cross-over 
integration of genes encoding green- and mCherry-fluorescent 
proteins (Shaner et al., 2004) into a dispensable gene locus, 
using a transfection vector that allows recycling of the drug-
selectable marker. These parasites are viable throughout the life-
cycle in mice and mosquitoes and can be used as a fluorescence 
mother-line. We tested this by adapting high efficiency 
large-insert PlasmoGEM vectors and used them to generate 
gene-modified fluorescent parasite lines (Pfander et al., 2011). 
Together, this toolkit provides a clear way forward for future 
expansion of gene targeting studies in P. chabaudi.
Methods
Ethical statement and mouse procedures at the University 
of Edinburgh
All procedures were carried out in accordance with the UK 
Home Office regulations (Animals Scientific Procedures Act 
1986; project licence number 70/8546 and P04ABDCAA) 
and approved by Ethical Review Body of the University of 
Edinburgh. Throughout this study, all efforts were made to 
reduce animal usage and ameliorate harm to animals. Mice were 
housed in the University of Edinburgh Licenced Animal 
Facilities 60/2605), and all animal procedures were performed in 
laboratories within the animal facilities. C57Bl/6Jax mice were 
bred under specific pathogen free conditions at the University 
of Edinburgh. Experimental female C57Bl/6 mice, aged six to 
twelve weeks, were kept in specific-pathogen-free conditions 
and subjected to regular pathogen monitoring by sentinel 
screening. Mice were housed with at least one companion in 
individually ventilated cages furnished with autoclaved 
woodchip, fun tunnel and tissue paper at 21 ± 2°C under a reverse 
light-dark cycle (light, 19.00 – 07.00; dark, 07.00 – 19.00) at 
a relative humidity of 55 ± 10%. Mice were housed under these 
light-dark cycle conditions to allow collection of P. chabaudi 
trophozoites prior to schizogony at 13.00-15.00 hrs, and were 
allowed to adapt to a reverse-light schedule for at least 7 days 
before P. chabaudi infection. They were fed a commercially 
available, autoclaved dry rodent diet (Rat and Mouse No. 3 
Breeding diet; Special Diets Services) and water, both available 
ad libitum. The health of mice was monitored by routine daily 
visual health checks, and P. chabaudi-infected mice were 
monitored at  least twice daily.
Mice, mosquitoes and parasites
The C57Bl/6 mouse/lPlasmodium chabaudi chabaudi AS 
animal model of malaria was chosen to minimize host genetic 
variability and to obtain robust infections with a very low 
incidence of severe disease. P.c. chabaudi AS parasites were 
obtained from the European Malaria Reagent Repository at the 
University of Edinburgh. Anopheles stephensi were maintained, 
and transmission of P. chabaudi was carried out, as described 
in (Spence et al., 2012; Spence et al., 2013). All experimental 
groups consisted of 2-6 mice housed together. Transfection 
experiments required 10 mice; two mice to provide infected 
blood for transfection and eight mice as recipients of parasites 
transfected with four plasmids in replicate. Parasite cloning 
required six mice and phenotypic experiments were carried out 
using groups of 7-8 mice, to provide statistical significance. 
Euthanasia was performed by cervical dislocation at the 
end of phenotypic experiments, or by exsanguination under 
anaesthesia (pentobarbital sodium; Euthatal). Mice were 
exsanguinated to obtain infected and uninfected blood for 
transfection experiments, or to collect genetically-modified 
parasites for storage as stabilates in liquid N
2
. This specific 
method of anaesthesia reduces animal suffering whilst maximising 
blood volume obtained.
Monitoring of infection
Female C57Bl/6Jax mice, aged 6-10 weeks with median weight 
of 22.5g (IQR 21.7g-23.1g), were inoculated ip with 1×105 
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PcAS-GFP
ML
-infected red blood cells and monitored for parasitae-
mia, weight loss and anaemia daily. Parasitaemia was enumerated 
either on giemsa-stained, thin-blood smears or by flow cytometric 
analysis (described in Underlying data; Thompson, 2020). In the 
latter case, 2µL of blood was diluted in 1mL of KSG-H (0.1 M 
NaCl, 4.6 mM KCl, 1.2 mM MgSO4·7H2, 25 mM Na
2
 HPO
4
, 0.2% 
(wt/vol) glucose, 25 IU ml-1 heparin sodium), made as described in 
(Spence et al., 2011), maintained at 4°C and then diluted a further 
1:5 prior to acquisition (150,000 events per sample) on a BD Fortessa 
analyser (Becton Dickinson, UK) within 2 hours of sampling. Using 
FlowJo analysis software (Becton Dickinson, UK), gating was 
performed on singlets (FSC-A v FSC-W), cells (FSC-A v SSC-
A) and native GFP (B530/30nm). Free Flow software, FCSalyzer, 
is available at https://sourceforge.net/projects/fcsalyzer/. GFP 
gates were set using uninfected blood, with a median of 0.06% 
background signal and a limit of detection threshold of 0.85% 
(n=42). For anaemia, haemoglobin (g/L) was determined by 
Hemocue Hb201+ analyser (Radiometer, Sweden) with moderate 
anaemia defined as 80-120 g/L and severe anaemia as <80 g/L, 
in accordance with WHO guidelines. The mean haemoglobin 
concentration in 36 uninfected control mice was 140 g/L (data 
was collected from mice at the point when they were assigned to 
experimental groups in this study).
Generation of circular transfection vectors
pCAT-230p-G6 was generated by replacing the sil6 target regions 
of pBAT-SIL6-G6 (Kooij et al., 2012) with bps 640-1680 and 
3312-4255 of the P. chaubaudi 230p (PCHAS_0308200) locus. 
The 230p target regions were amplified from P.c. chabaudi 
AS genomic DNA using primers 5’230pF x 5’230p (5’ target region) 
and 3’230pF x 3’230pR (3’ target region) and cloned into the multiple 
cloning sites of pBAT-Sil6-G6 or –M6 to generate pCAT-230p-G6 
or pCAT-230p–M6. Plasmids to delete PCHAS_0812700 
(PcCRMP1) were generated by replacing the sil6 target regions 
of pBAT-SIL6-M6 with bp 2-778 (5’) and 6855-7849 (3’) of 
pccrmp1.
Construction and mapping of PlasmoGEM P. chabaudi 
genomic clone libraries
PlasmoGEM, the Plasmodium genetic modification project, is a 
collaborative project at the Wellcome Sanger Institute with the goal 
of developing, distributing and applying large-scale resources for 
Plasmodium genetic modification.
Blood stage P. chabaudi AS parasites were purified using 
Plasmodipur (EuroProxima) and MACS Columns (Miltenyi 
Biotec). Parasite genomic DNA was purified using the Qiagen 
DNeasy Blood & Tissue Kit (catalogue # 69504). Nuclear DNA 
was isolated from the preparation (removing the 6 kb mitochon-
drial genome) by gel electrophoresis and purification of the high 
molecular weight nuclear genome band. Libraries of genomic 
DNA inserts were generated using the BigEasy v2.0 Linear 
Cloning System (pJAZZ-OK Blunt Vector, Lucigen, USA; 
catalogue # 43036-1) as described (Pfander et al., 2011). Briefly; 
10 µg genomic DNA was mechanically sheared and end-repaired 
using mung bean nuclease prior to ethanol precipitation. DNA 
was pelleted and resuspended in TE buffer, then size selected on 
a 0.8% agarose gel. DNA fragments of 6-8, 8-10 and 10-15 kb 
were excised, purified and end-repaired using the Lucigen kit. 
After an additional gel size selection, each insert size range 
was ligated individually into the pJAZZ vector. The duplicated 
end-repair and size-selection steps improves cloning efficiency 
and accuracy of size selection. Ligation reactions were purified 
using phenol:chloroform extraction and ethanol precipitation, 
and resuspended in dH
2
O prior to electroporation into BigEasy 
TSA cells (Lucigen, USA, catalogue # 60224-1). TSA cells 
harboring P. chabaudi genomic library clones within pJAZZ 
vectors were propagated in Terrific Broth (TB) medium 
supplemented with 0.4% glycerol and 30 µg/ml kanamycin 
as recommended by the manufacturer, without arabinose 
induction.
Plasmodium chabaudi genomic library (PcG01 and PcG02) 
clones were arrayed on 96-well plates and subjected to 
capillary sequencing of the gDNA ends. To locate each gDNA 
insert, each library clone was mapped to version 3 of the 
P. chabaudi (AS strain) genome (Otto et al., 2014), using 
SMALT (version 0.7.5) as described previously (Pfander et al., 
2011).
Design and generation of PlasmoGEM gene targeting 
vectors for P. chabaudi
We created designs for all possible gene knock-out and c-terminal 
tagging vectors with the gDNA inserts using a custom software 
pipeline as previously described for generating a P. berghei resource 
(Schwach et al., 2015).
Plasmids and protocols for the parallel recombinase-mediated 
engineering (recombineering) of PcG01 and PcG02 library 
clones on 96-well plates were the same as used previously 
for the generation of P. berghei vectors (Pfander et al., 2011). 
Briefly, (1) TSA cells harboring PcG01 and PcG02 library 
clones were made transiently recombineering-competent by 
introduction of the pSC101gbdA plasmid that encodes elements 
of the red/ET operon of bacteriophage lambda (Zhang et al., 
1998). (2) The target genes encoded by the PcG01 and PcG02 
library clones were subsequently modified by site-specific 
recombineering mediated by 50 bp homologous targeting 
regions so to delete or disrupt the open reading frame (knock-
out vectors), or delete the stop codon (tagging-vectors). The 
recombineering step introduces a dual (zeo-pheS) bacterial 
selectable marker which confers resistance to zeocin and sen-
sitivity to 4-chloro-DL-phenylalanine. (3) In a LR-Gateway 
Clonase I (Thermofisher, catalogue # 11791042) mediated reac-
tion with the pR6K attL1-3xHA-hdhfr/yfcu-attL2 plasmid, which 
also introduces a 3xHA epitope tag (silent in KO parasites), the 
zeo-pheS selection cassette was then replaced by a mutated 
version of human dihydrofolate reductase (hdhfr) coupled to 
uridyl phosphoribosyl transferase (yFCU), which confers resist-
ance to pyrimethamine and sensitivity to 5-fluorocytosine 
(5-FC) in Plasmodium. Final vectors were subjected to full-
length Illumina sequencing on a MiSeq platform to confirm the 
correct sequence of the homology arms before uploading 
design data to our public resource at https://plasmogem.sanger.
ac.uk (Schwach et al., 2015).
SC101gbdA was propagated at 30°C in DH10B cells in 2x 
low salt Luria Broth (LB) with 5 µg/ml tetracycline, or together 
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with pJazz library clones in TB medium with 0.4% glycerol + 
30 µg/ml kanamycin + 5 µg/ml tetracycline in TSA cells. The 
SC101gbdA and pR6K attR1-zeoR-PheS-attR2 plasmid served 
as template for the amplification of the zeo-PheS cassette for 
the recombineering step. These plasmids were kind gifts from 
Francis Stewart, Dresden. The Gateway donor plasmid pR6K 
attL1-3xHA-hdhfr/yfcu-attL2 was the same as used for 
P. berghei PlasmoGEM vectors (Pfander et al., 2011). The 
R6K origin of replication plasmids were propagated in PIR1 
(Invitrogen) bacteria in LB Broth with 5 µg/ml tetracycline.
Transfection
For transfection, plasmid DNA was prepared using Qiagen plas-
mid midi-kit (catalogue # 12143). Circular vectors were linearised 
with restriction enzymes AatII and ApaLI (New England 
Biolabs) and purified away from the plasmid backbone using 
gelelectrophoresis and a Qiagen QIAquick gel purification kit 
(catalogue # 28704), according to the manufacturer’s instructions. 
DNA was resuspended in dH
2
O at 0.2–1 µg/µl. The PlasmoGEM 
transfection vectors used to delete pccrmp1 (PCHAS_0812700), 
pccrmp2 (PCHAS_ 0617600), pccrmp3 (PCHAS_0608500), 
pccrmp4 (PCHAS_1304000) and PCHAS_0418000 
were PcGEM-600068, PcGEM-597076, PcGEM-596604, 
PcGEM-610764 and PcGEM-594684, respectively. The Plas-
moGEM vectors were propagated in E. coli TSA cells (Lucigen, 
USA) according to PlasmoGEM protocols (Pfander et al., 2011; 
Pfander et al., 2013) and inserts were released by NotI digestion, 
followed by standard ethanol precipitation.
P. chabaudi schizont culture
The culture of P. chabaudi trophozoites to mature schizonts was 
carried out exactly as described in (Spence et al., 2011) with the 
following modifications. To provide parasites for culture, a single 
wild-type donor C57Bl/6Jax mouse (female, 6-10 weeks) was 
injected ip with 1-5 x 107 parasites. At day 3 of infection (parasi-
taemia 19–45%), the mouse was exsanguinated at 12.00 hrs, and 
the infected red cells were cultured at 37°C under 5% O
2
, 5% CO
2
, 
90% N
2
 in 10 ml complete-RPMI (RPMI 1640 (Invitrogen), 10% 
(vol/vol) FBS (PAA Laboratories), 6 mM HEPES, 2 mM l-glutamine, 
0.5 mM sodium pyruvate and 50 µM β-mercaptoethanol). After 
2 hours of culture, flasks were carefully removed from the 
incubator without disturbing the sedimented cells and maintained 
at 37°C by placing onto a pre-warmed heat-block or flask. Five ml of 
culture supernatant was aspirated and replaced with complete-RPMI 
containing 2 µl of 10 mM compound 2 (C2) Collins et al., 2013). 
Flasks were re-gassed and returned to the 37°C incubator for a 
further 2.5 h. C2 was later replaced with ML10, a trisubtituted 
thiazole Plasmodium cGMP-dependent protein kinase (PKG) 
inhibitor (Tsagris et al., 2018), which was found to reversibly 
inhibit the egress of mature schizonts in culture comparably 
to C2 at concentrations of 0.1-1 µM. ML10 is available from 
LifeArc.
Transfection and selection of fluorescent P. chabaudi 
parasites
After 4 hours of culture (30 minutes before the end) a single 
uninfected wild-type C57Bl/6Jax mouse (female, 6-10 weeks) 
was exsanguinated to provide fresh red blood cells for invasion by 
merozoites after electroporation. This uninfected blood was 
suspended in 10 ml of complete-RPMI and cells were pelleted 
by centrifugation at 400g for 5 min. The pellet was then resus-
pended in complete-RPMI to a final volume of 800 µl, and 100 
µl aliquots were transferred into 1.5 ml tubes maintained in a 
heat-block at 37°C.
After 4.5 hours of culture (now enriched in mature arrested 
schizonts), flasks were carefully removed from the incubator 
without disturbing the sedimented cells and up to 9 ml of culture 
supernatant was removed by aspiration and replaced with 10 ml 
complete-RPMI. Cells were resuspended by gently shaking the 
flask and 1ml aliquots were transferred to 1.5 ml tubes maintained 
in a water-bath at 37°C. Cells were pelleted by centrifugation for 
20 sec at 2000 rpm in a microcentrifuge and 5 µl of packed cells 
were transferred to a tube containing 1–5 µg of linearized plas-
mid in 5-10 µl dH
2
O with 100 µl basic parasite Nucleofector II 
solution. Cells were gently resuspended, transferred to a cuvette 
and electroporated in a Nucleofector II (Lonza) using program 
U-033. Immediately following electroporation, cells were 
transferred to the tubes containing 100 µl aliquots of fresh red 
blood cells and maintained at 37°C until all transfections were 
completed. Each tube of transfected parasites was then injected 
iv into a single wild-type recipient C57Bl/6Jax mouse (female, 
6-10 weeks) as described (Spence et al.. 2011). From 24 hours 
after transfection, recipient mice were supplied with acidified 
drinking water supplemented with pyrimethamine (35 µg/ml), 
refreshed every day for 5-12 days until parasites were visible. Mice 
were exsanguinated by cardiac puncture under terminal anaesthesia 
to collect infected blood. Correct integration of the resulting 
PcAS-GFP.Δ230p and PcAS-mCh.Δ230p parasites (and deletion 
of 230p) was confirmed by diagnostic PCR using Phusion Blood 
Direct PCR kit (ThermoFisher Scientific; catalogue # 15280114). 
All PCR reactions were carried out using an MJ Research DNA 
Engine, PTC-200. 50 µl reaction mixes contained 25 µl 2x Phusion 
Blood PCR buffer, 1 µl (0.5 µM) Primers F and R, 1 µl Phusion 
Blood DNA polymerase, 1 µl whole blood, 22 µl dH
2
O. The cycling 
protocol was: one cycle x 98°C, 5 min; 40 cycles x 98°C, 1 sec, 
72°C, 30sec; one cycle x 72°C, 1 min.
Recycling of the drug selection cassettes
Following confirmation of plasmid integration into the 230p locus, 
1 x 105 PcAS-GFP.Δ230p parasites were injected ip into four 
wild-type C57Bl/6Jax mice. After 24 h (one cycle of replication), 
mice were supplied with the pro-drug 5-fluorocytosine in the 
drinking water (0.5 mg/ml) for 5 days until the parasitaemia of the 
recycled parasites reached 0.15%. Mice were exsanguinated by 
cardiac puncture under terminal anaesthesia to collect infected 
blood.
Recombination-mediated removal of the drug selectable cassette 
was determined by diagnostic PCR as described above (Phusion 
Blood Direct PCR Kit) and the ratio of recombined (primers recF x 
recR amplicons) to non-recombined parasites (dF x dR amplicons) 
was compared after 20, 25 and 30 cycles of PCR (Figure 1D). 
PcAS-GFP
ML
 parasites showing a ratio > 2:1 recombined: 
non-recombined parasites were cloned by limiting dilution. 
Complete recombination and removal of hDHFR was then 
confirmed by diagnostic PCR as described above using primers 
recF x recR and dFxdR. A full list of primers used are provided in 
Table 1.
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Figure 1. Transfection of P. chabaudi AS to create PcAS-GFPML . A) Mature P. chabaudi AS schizonts accumulate after 4.5 hours of culture 
in the presence of C2 (giemsa-stained smear); infected erythrocytes were smeared 5 minutes after C2 was removed from culture. Merozoites 
undergoing erythrocyte invasion are arrowed. B) Schematic representation of the pCAT230p-G6 plasmid showing hDHFR and yFcu selectable 
cassettes, the GFP cassette and 3’PbDHFR-TS direct repeats, allowing recombination and excision of the drug-selectable cassette. C) 
Stable integration of GFP into the pc230p locus. To verify correct integration into the pc230p locus in PcAS-GFP.Δ230p DNA, 1.4kb and 1kb 
fragments were amplified from the 5’ and 3’ integration sites using primers 5’intF x 5’intR and 3’intF x 3’intR, respectively. To verify deletion of 
pc230p, primers 230pF x 230pR were used to amplify a 0.37kb fragment in wild-type but not PcAS-GFP.Δ230p DNA. To verify the presence of 
hDHFR, primers dF1 x dF2 were used to amplify a 461bp fragment in PcAS-GFP.Δ230p but not in wild-type or PcAS-GFPML DNA. D) Recycling 
of the drug-selectable cassettes. Following selection with 5-FC, recombined parasites excised the drug-selectable cassettes (insert) and an 
830bp fragment was amplified from PcAS-GFPML DNA using primers recF x recR.
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Table 1. Primers. Restriction enzyme sites are underlined
5’230pF 
5’230pR 
3’230pF 
3’230pR 
5’intF (230p) 
5’intR (230p) 
3’intF (230p) 
3’intR (230p) 
230pF 
230pR 
dF 
dR 
recF 
recR 
crmp1F 
crmp1R 
crmp1F2 
crmp1R2 
5’intF (crmp1) 
5’intR (crmp1) 
3’intF (crmp1) 
3’intR (crmp1) 
GW1 
GT1 (crmp1) 
GT1 (crmp4) 
Crmp4F 
Crmp4R
atattGCCGGCTCATGTTATAACTAGACCATCG 
ttattACTAGTGTACTACCATCTGTTACAC 
atattCTCGAGGAATTCTCTTGAACCCGTGGATG 
ttattGACGTCGTATGGAACTACATCTATGTAGGAAACTTG 
GTTATAATTTGTTCGAAACCCTC 
TAGTATGCACCCTTTGAGGGC 
AGTAAGAAAAAACGCGTGG 
CAGTAAAATCACAAACATAAGTATCG 
GAAAATCCAGAATATGCGTTAGC 
GACAATGTAATGCTACATATTCTAACG 
CACCTGGGTATTCTGGC 
TCAGAACATGGGCATCG 
GGCCAATTAAAGATAACATCAACATTGAT 
TTGGACATTTAACTTGAACC 
ACATATTCACGCCAGGAC 
TATTCCGCGGATGACAGCTTGAGACTTCTG 
TCGTGCCCTTTAAATGCACACA 
AGCTCTCTTTGTATCCTCATGCA 
TGATGTATTCCCCCCTTCTC 
TAGTATGCACCCTTTGAGGGC 
AGTAAGAAAAAACGCGTGG 
TGGAAATATTGGGTATTGGC 
CTATTCATACTAGCCATTTTATGTGTG 
ATATGAAGTGGATGTATTTCGC 
AAGTAAAAGTCCCATCTGGC 
TGCATGCACCTGAGTGAATT 
ACTTTGAAGCAATCGCACAA
Results
Design of transfection vectors
P230p has been reported to be dispensable for asexual parasite 
replication in P. falciparum, P. berghei, P. yoelii and P. knowlesii 
(Hart et al., 2014; Moon et al., 2013; Thomas et al., 2016; van Dijk 
et al., 2010). To generate parasites that can be used as fluores-
cent reference lines throughout the P. chabaudi lifecycle, we 
modified the pBAT-SIL6 plasmid set (Kooij et al., 2012) to gen-
erate plasmids that would recombine within the P. chabaudi 
230p locus and introduce genes encoding green or mCherry 
fluorescent proteins, expressed under the control of the strong 
and constitutive P. berghei HSP70 5’ UTR promoter. Plasmids 
pCAT
230p
-G6 and pCAT
230p
-M6 also contained cassettes encoding a 
pyrimethamine-selectable marker (hDHFR) to enable positive 
selection for transfectants, as well as negative selectable markers 
yeast cytosine deaminase and uridyl phosphoribosyl transferase 
(yFCU; confers sensitivity to 5-fluorocytosine (5-FC)) flanked by 
pbdhfr-ts 3’utr duplicate sequences, which promote recombina-
tion and recycling of both drug-selectable markers after negative 
selection with 5-FC (Figure 1B).
Generation of stable, marker-freefluorescent  
P. chabaudi mother-lines
Transfection in rodent malaria parasites relies on electroporation 
of merozoites (the extracellular stage of the blood cycle), which 
become mechanically released from arrested schizonts during the 
isolation procedure, and then subsequently re-invade host reticu-
locytes or erythrocytes after injection into the bloodstream of a 
recipient mouse. It is likely that transfection efficiency is lower in 
P. chabaudi than in other rodent malaria models because schizont 
rupture and re-invasion of mature erythrocytes occurs spontane-
ously in culture, hindering the collection of large populations 
of arrested schizonts. Therefore, to improve the efficiency of 
P. chabaudi transfection, we tested whether the reversible inhibitor 
of the Plasmodium PKG - C2 (Collins et al., 2013) - could cause 
schizonts to arrest and accumulate in culture, thereby increasing the 
number of viable merozoites available for electroporation.
Addition of C2 at a concentration of 2 µM to the parasite culture 
led to the accumulation of > 55% mature schizonts (Figure 1A). 
Removing C2 (by simply replacing the C2-supplemented media 
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with fresh culture media) allowed normal schizogony to resume 
and these enriched schizonts could then be electroporated in the 
presence of plasmids pCAT
230p
-G6 or pCAT
230p
-M6 (Figure 1B). 
Next, electroporated merozoites were transferred into tubes con-
taining uninfected mouse erythrocytes held at 37°C to provide an 
immediate high-density source of fresh red cells for invasion and 
ring-formation. This step buys enough time (at least 45 minutes) 
for multiple transfection procedures to be carried out in the labo-
ratory before the transfectants need to be injected into recipient 
mice. Significantly, these two protocol modifications improved the 
efficiency of transfection to such an extent that merozoites could 
be injected directly into wild-type mice, removing the need for 
 immunodeficient mouse strains for parasite expansion and drug 
selection. In these ways, we could improve the efficiency, practi-
cability and accessibility of this technique. In our laboratory, we 
have successfully achieved transformation using pCAT-modified 
vectors targeting six non-essential loci, with transformed parasites 
becoming patent at days 9-14 after transfection.
To generate stable, marker-free fluorescent P. chabaudi 
mother-lines, plasmids pCAT
230p
-G6 and pCAT
230p
-M6 were trans-
fected into P. chabaudi AS parasites according to this modified 
protocol to introduce GFP and mCherry into the P. chabaudi 230p 
silent locus by double cross-over recombination. After pyrimeth-
amine selection of PcAS-GFP.Δ230p and PcAS-mCh.Δ230p 
parasites and genotypic verification (Figure 1C), PcAS-GFP.
Δ230p–infected mice were provided with 5-FC to select parasites 
that had lost the drug-selectable cassettes by homologous 
recombination of pbdhfr-ts 3’utr duplicate sequences. The 
resulting marker-free fluorescent parasites were cloned by limiting 
dilution to produce the mother-line, PcAS-GFP
ML
.
Fluorescent PcAS parasites transmit through the mosquito 
and show wild-type infection dynamics
PcAS-GFP
ML
 parasites express GFP strongly throughout the 
lifecycle and, as with wild-type P. chabaudi -AS, undergo 
schizogony and re-invasion of erythrocytes in static culture 
(Figure 2A). PcAS-GFP
ML
 schizont-infected erythrocytes 
also display  wild-type cytoadhesion properties by forming 
rosettes with uninfected erythrocytes (Figure 2A) and PcAS-
GFP
ML
 parasites efficiently transmit through the mosquito, giv-
ing rise to oocysts (Figure 2Bi)and salivary gland sporozoites 
(Figure 2Biii). Moreover, they establish acute and chronic infec-
tions with the same dynamics as wild-type parasites, and 
demonstrate attenuated growth and virulence after mosquito 
transmission (Figure 3) (Spence et al., 2013). PcAS-GFP
ML
 
parasites can therefore be used to investigate every step of the 
Plasmodium life cycle.
PlasmoGEM resources for P. chabaudi
We have previously generated large gene deletion and tagging 
vectors libraries for modification of the P. berghei 
genome (Gomes et al., 2015). Scalability relies on robust, parallel 
engineering of vectors in 96-well plates using the red/ET recom-
binase system, which in turn requires an arrayed gDNA library, 
which we constructed in a phage N15-derived linear cloning 
system with hairpin telomers (Pfander et al., 2011; Zhang et al., 
1998). The low copy number of the pJAZZ cloning vector 
facilitates serial recombineering, and due to its linear nature 
it can maintain relatively large AT-rich gDNA fragments 
(Godiska et al., 2010), resulting in targeting vectors with large 
homology regions and high integration rates (Pfander et al., 
2011). Furthermore, since pJAZZ plasmids in our hands are not 
maintained as episomes when transfected into P. berghei, the 
background noise in transfection experiments is much reduced, 
such that within a few days of transfection, barcode counting 
on a sequencer can be used to phenotype dozens of mutants 
simultaneously (Bushell et al., 2017; Gomes et al., 2015).
Figure 2. A) PcAS-GFPML undergoes schizogony, rupture and 
rosetting with uninfected erythrocytes in culture. PcAS-GFPML 
trophozoites from infected mice were cultured for 4.5 hours in the 
presence of C2. At 4.5hr and in the presence of C2; i) schizont-
infected erythrocytes form rosettes with uninfected erythrocytes; 
left–hand panel, merged bright and fluorescent fields; right-
hand panel, fluorescent field. At 4.5hr and after removal of C2; 
ii) merozoites egress from schizonts and iii) invade erythrocytes 
(arrowed); merged bright and fluorescent fields. B) PcAS-GFPML 
transmit to the mosquito; i) oocysts in the midgut (day 8), ii) midgut 
sporozoites and iii) salivary gland sporozites (day 14). Scale 
bar = 5μm.
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To create PlasmoGEM resources for P. chabaudi, we needed to 
create such an arrayed library from P. chabaudi genomic DNA. 
We created a gDNA library in the pJazz-OK Blunt cloning vector, 
consisting of 7104 clones, of which 5523 could be mapped to 
version 3 of the P. chabaudi genome (Otto et al., 2014) with an 
average insert size of 6.7kb (Figure 4A). The cloning efficiency 
(73%) was similar to our previously generated P. berghei gDNA 
library resource (Pfander et al., 2011). The library covers at least 
50% of the coding-sequence of 4167 protein-coding genes (equiva-
lent to a coverage of 80.7% of all predicted genes in the assem-
bled genome); 3392 (65.7% coverage) genes are covered fully. 
Using our previously described software, we created automated 
designs for knock-out vectors for 3665 genes (70.9% coverage) and 
c-terminal tagging vectors for 3141 genes (60.8% coverage), 
which are available on our website at https://plasmogem.sanger.ac 
(Schwach et al., 2015).
Our initial targets for knock-out vectors were genes implicated 
in signal transduction, and those predicted to encode exported 
proteins using a number of criteria including existing 
annotation of gene function, presence of transmembrane domains 
and ExportPred algorithm scores (Sargeant et al., 2006), Using our 
recombineering pipeline (Pfander et al., 2011), we produced a first 
batch of 406 (7.9% coverage) barcoded single-gene knock-out 
vectors that passed quality control by full-length sequencing 
(Figure 4B). The vectors are available to request as part of the 
PlasmoGEM project.
High efficiency transformation of wild-type and  
PcAS-GFPML P. chabaudi using PlasmoGEM vectors
To compare the efficiency of transfection between modified pCAT 
plasmids and pJAZZ-derived PlasmoGEM long homology-arm 
gene disruption vectors, we targeted loci encoding p230p and 
genes encoding members of the P. chabaudi Cysteine Repeat 
Modular Protein (PcCRMP) family, which are not essential for 
blood-stage replication (Thompson et al., 2007), in wild-type 
P. chabaudi AS. As an example, the strategy used to modify the 
PCHAS_081270 locus, encoding PcCRMP1, is shown in Figure 5. 
Patent parasitaemia was observed in pJAZZ vector-transfected lines 
on day 8–9 following infection and in pCAT vector-transfected 
lines on day 10–14 (Figure 5C), suggesting that pJAZZ vectors 
confer > 64-fold higher transfection efficiency (assuming 
P. chabaudi AS has an 8-fold proliferation rate/cycle).
To next compare the transfection efficiency of PcGEM vec-
tors in wild-type and PcAS-GFP
ML
parasites, we transfected a 
construct targeting PcCRMP4 (PCHAS_1304000; Figure 5D). 
PcCRMP4-deletant parasites were patent by day 9 post-transfec-
tion in both parasite lines and showed integration into the pcccrmp4 
locus and deletion of the gene. Thus, we have demonstrated 
Figure 3. The virulence of PcAS-GFPml parasites is reset by mosquito transmission and increases after serial passage. C57Bl/6Jax 
mice were inoculated ip with 1x105 infected red blood cells of PcAS-GFPml, two blood passages from a mosquito-transmitted inoculum 
(mt- PcAS-GFPml) or with 1x10
5 infected red blood cells of PcAS-GFPml that had been serially blood-passaged (sbp PcAS-GFPml). Data shown 
as a pool of n=7 mice for mt PcAS-GFPm and n=8 mice for sbp PcAS-GFPml, with mean ± SEM. i) Parasitaemia from tail blood, determined 
by Giemsa stain and by flow cytometric analysis. ii) Percent weight change from day 0 post infection (p.i.) with mt PcAS-GFPml. iii) Anaemia 
from day 0 post infection (p.i.) with mt PcAS-GFPML defined using circulating haemoglobin (Hb g/L) levels, determined by tail blood with a 
Hemocue analyser. Moderate anaemia is defined as 120 g/L and severe anaemia defined as 80 g/L (dotted lines).
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Figure 4. Generation of PlasmoGEM resources for genetic modification of P. chabaudi. Insert-size distribution for P. chabaudi genomic 
DNA (gDNA) clone library showing number of clones for each genomic insert-size category, with an average genomic clone size of 6-7 kb 
(A). Size selected P. chabaudi genomic DNA fragments (ii) were cloned into the pJAZZ-OK Blunt vector (i) to generate the PcG01 and PcG02 
genomic libraries. The pJAZZ-OK Blunt vector encode hairpin telomers (shown in black), a telomerase gene (TelN), replication factor and 
origin (repA), regulator of replication (cB) and a kanamycin resistance gene (kanR). Genomic library clones are converted into gene targeting 
vectors by recombineering, which introduces a dual bacterial selectable marker zeocin-pheS (zeo-pheS), (iii). Linear transfection-ready 
vectors are then generated by Gateway cloning, which facilitates the exchange of the zeo-pheS cassette for the parasite positive-negative 
selection marker human dihydrofolate reductase-uridyl phosphoribosyl transferase (hdhfr-yfcu), (iv) that are prepared for transfection by NotI 
digest and integrate with high efficiency into the P. chabaudi genome (v).
the generation of marker-free fluorescent mother-lines that can 
now be genetically-modified using the high-efficiency vectors, 
available from PlasmoGEM, This enhanced toolbox is now 
ready to kick-start Plasmodium chabaudi genetic studies
Summary
The improvements in the efficiency, practicability and accessibility 
of P. chabaudi transfection techniques reported here have enabled 
us to reproducibly generate a series of fluorescently-tagged and 
gene-deletion parasite lines. Transfections were carried out using 
transfection vectors derived from the versatile pBAT series of 
plasmids (Kooij et al., 2012) that can rapidly be adapted 
for use in gene targeting and tagging strategies, and we 
have used these to generate fluorescent lines of distinct 
P. chabaudi genotypes (unpublished report). These plasmids 
also allow recycling of the positive drug-selectable marker and, 
therefore, sequential genetic modifications. For P. chabaudi, this 
feature may be particularly useful for analysis of the function 
of multigene families that are not individually essential for 
blood-stage replication but have been proposed to play a role 
in immune evasion and modulation, including members of the 
Plasmodium Cysteine Repeat Modular Protein (PCRMP) 
family (Douradinha et al., 2011; Thompson et al., 2007). Thus, 
we can now study the function of the multi-gene families dur-
ing both acute infection and chronicity in the face of the host 
immune response, and we can explore whether family members 
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have overlapping and compensatory roles by performing double 
and multiple gene deletions, making use of our ability to recycle 
the selection marker using negative selection.
We have generated a genome-scale P. chabaudi genomic library 
that can effectively be converted into PlasmoGEM linear, long 
homology arm gene targeting vectors that integrate into the 
P. chabaudi genome with high transfection efficiency. This 
PlasmoGEM P. chabaudi vector resource can now be used 
together with these fluorescent mother-lines to perform high 
throughput pooled genetic screens (Gomes et al., 2015); for 
example, to identify parasite genes essential for sexual 
commitment and transmission during chronic infection. We 
therefore expect that these improvements in genetic modifica-
tion of P. chabaudi will encourage the research community to 
adopt this model to answer new research questions that cannot be 
addressed effectively in other mouse models of malaria.
Data availability
Underlying data
PlasmoGem vector sequence and design data are available as a 
public resource at https://plasmogem.sanger.ac.uk.
Open Science Framework: Marr et al. An enhanced toolkit for the 
generation of knockout and marker-free fluorescent Plasmodium 
chabaudi. https://doi.org/10.17605/OSF.IO/65RW3
Figure 5. Modification of non-essential loci with pCAT and pJazz plasmids. A) Left hand panel (LHP); schematic representation of the 
pCATcrmp1-M6 plasmid and the pccrmp1 locus after transfection. Right hand panel (RHP); to verify correct integration into the pccrmp1 locus, 
1.22kb and 1.17kb fragments were amplified from the 5’ and 3’ integration sites using primers 5’intF.crmp1 x 5’intR.crmp1 and 3’intF.crmp1 
x 3’intR.crmp1, respectively. To verify deletion of pccrmp1, primers crmp1F x crmp1R were used to amplify a 306bp fragment in wild-type 
but not PcAS-mCh.Δcrmp1 DNA. To verify the presence of hdhfr, primers dF1 x dF2 were used to amplify a 461bp fragment in PcAS-mCh.
Δcrmp1 but not in wt DNA. B) LHP; schematic representation of the PGEM-600068 construct and the pccrmp1 locus after transfection. RHP; 
to verify correct integration into the pccrmp1 locus, a 2.9kb fragment was amplified from the 3’ integration site using primers GW1 x GT1.
crmp1. To verify deletion of pccrmp1, primers crmp1F2 x crmp1R2 were used to amplify a 627bp fragment in wt but not PcAS.Δcrmp1 DNA. 
To verify the presence of hdhfr, primers dF1 x dF2 were used to amplify a 461bp fragment in PcAS.Δcrmp1 but not in wt DNA. C) Day of 
patency following transfection with pCAT plasmids (n=6) and pJazz constructs (n=8) targeting non-essential loci. Parasitaemia was 
monitored by giemsa stain from days 7-16 following transfection. Patency was determined when parasitaemia was at least 0.005%. D) LHP; 
schematic representation of the PGEM-610754 construct and the pccrmp4 locus after transfection into P. chabaudi AS wild-type and PcAS-
GFPmlparasites. RHP; to verify correct integration into the pccrmp4 locus, a 3.3kb fragment was amplified from the 3’ integration site using 
primers GW1 x GT1.crmp4. To verify deletion of pccrmp4 in wild-type and PcAS-GFPmlparasites, primers crmp4F x crmp4R were used to 
amplify a 700bp fragment in wild-type but not PcAS.Δcrmp1 DNA. To verify the presence of hdhfr, primers dF1 x dF2 were used to amplify a 
461bp fragment in PcAS.Δcrmp4 but not in wild-type DNA. 
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This project contains the following underlying data: 
-    Original gel and microscopy images for Figures 1, Figure 2 
and Figure 5 in TIF/TIFF format
-   pCAT plasmid sequences in DOCX format
-    Raw parasitaemia, weight change and anaemia data 
underlying Figure 3 in XLSX format
-    Raw data underlying Figure 5C in XLSX format (Tfn_
pCATvpJAZZ)
-   Gating strategy for peripheral parasitemia in PPTX format
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Attribution 4.0 International license (CC-BY 4.0).
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Malaria in humans is caused by more than 7 different species of protozoan parasite within the 
genus, with  causing the majority of disease and death. Studies intoPlasmodium  Plasmodium falciparum
the biology of malaria parasites primarily rely on the use of a few species of human malaria parasites that
can be cultured in vitro and 3 different species of rodent malaria parasites which can be maintained in
mice in the lab. The functions of a majority of proteins are conserved across all species, so the use of
multiple species allows us to make use of key experimental advantages of each system to uncover
shared biology. It also offers the opportunity to compare and contrast results to study key differences
between the species. Whilst the transfection technology for the rodent malaria parasite   hasP. chabaudi
lagged behind other species, it none the less has proved invaluable in the study of key aspects of
host-parasite interactions. This work addresses a key current drawback in the   model with theP. chabaudi
presentation of  3 significant advancements in experimental genetics approaches – optimisation of
transfection efficiency, generation of marker-less transgenic lines and generation, and testing of a P.
 plasmoGEM construct library. The work provides a major technical advancement for the modelchabaudi
and provides an important new resource for the field.
The comments are all minor but I hope should provide some small improvements to the paper.   
General comments:
“two mice to provide infected blood for transfection and eight mice as recipients of parasites
transfected with four plasmids in replicate” Why were two mice used for each plasmid per
transfection? For replicates, it would be more appropriate to carry these out across different
parasite preparations/transfections which are likely the biggest variable for transfection efficiency.
 
“a custom software pipeline as previously described for generating a   resource” WhilstP. berghei
the reference describes general parameters an additional direct link to the software and source
code (journal requirement) should be added. The version number of software used should also be
made clear, I imagine it may be different between the two papers.
 
Images in fig1 (smears) are very low quality. I don’t dispute the interpretation but it is very difficult to
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Images in fig1 (smears) are very low quality. I don’t dispute the interpretation but it is very difficult to
see the condition of the parasites in that resolution.
 
“we tested whether the reversible inhibitor of the   PKG - C2 ( )” isPlasmodium Collins  , 2013et al.
this the right reference? C2 is not used for synchronisation in this paper. Perhaps it should be 
 (which has the same first author and year).https://doi.org/10.1371/journal.ppat.1003344
 
C2 has been used in  for transfections for similar reasons. Here viable was found toP. knowlesii 
decrease if held beyond 3 hours. Could the authors comment on the incubation time used (4.5 h)
and whether loss of viability was detected after longer incubations? This will help guide correct
usage by other labs.
 
“undergo schizogony and re-invasion of erythrocytes in static culture ( )” to what extentFigure 2A
can  be cultured longer term? Can you provide an indicator as to relative growth rate P. chabaudi in
, or whether it can be maintained for multiple cycles? If this has been demonstrated previouslyvitro
could this reference be added?
 
Figure 2 title seems to relate to just panel A, the title could be changed to include a reference to
transmission states and A) moved to the second sentence. Scale bars are only indicated in one
image each for A/B i, ii, iii, but the images are at different magnification. The sporozoite images
appear to be at a much greater magnification so need a separate scale bar. The data from Figure 3
are also duplicated in the figure image.
 
“terminal tagging vectors for 3141 genes (60.8% coverage), which are available on our website at 
” hyperlink truncated.https://plasmogem.sanger.ac
 
Summary - I would additionally suggest some discussion of where these technologies fit into the
wider scheme of those used in other systems. Combining the optimisation of transfection with
Cas9 based approaches, and the huge vector resource available through PlasmoGEM could
create a formidable system. Also highlight one of the current downsides of the PlasmoGEM system
which is that the markers cannot be recycled.
 
Summary -  reinvasion is mentioned, could short term culture be used for transfectionIn vitro 
recovery to reduce animal use?
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Are sufficient details provided to allow replication of the method development and its use by
others?
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If any results are presented, are all the source data underlying the results available to ensure full
reproducibility?
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Are the conclusions about the method and its performance adequately supported by the
findings presented in the article?
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   Tania F. de Koning-Ward
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This paper describes the generation of a new fluorescent  mother line that can be used toP. chabaudi 
knockout and tag genes using the  specific PlasmoGEM vectors that have also been createdP. chabaudi 
as part of this study. Together this line and the PlasmoGEM vectors will facilitate the study of gene
function in  a rodent species that causes a chronic infection with periodic rescrudescence asP. chabaudi, 
a result of its antigenic variation. Hence the ability to genetically manipulate this rodent malaria species
will be of value to malaria researchers.
The methodologies were thoroughly described, the results are robust and conclusions valid. My
comments really relate to improving the manuscript for clarity. 
I found the methodology described in the second paragraph of the 'Design and generation of
PlasmoGEM gene targeting vectors for P. chabaudi' somewhat confusing and whilst this is
schematically presented in Figure 4 it would be good to label (i), (ii), etc  and for example indicate
which is the pR6K attL1-3xHA-hdhfr/yfcu-attL2 plasmid so that the steps described in the methods
can be readily followed in the figure. Also for this figure legend, reword so that mention of (i) comes
before (ii). Also show where NotI cuts in the figure.
 
PCR step in 'Transfection and selection of fluorescent P. chabaudi parasites' - it looks like the
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2.  
3.  
4.  
5.  
6.  
7.  
8.  
9.  
PCR step in 'Transfection and selection of fluorescent P. chabaudi parasites' - it looks like the
annealing step has been omitted.
 
Figure 1: include the primers used for the PCRs underneath the figure for greater clarity. E.g.
presumably in Fig 1B df/dr was used in first panel and recF and recR in second?
 
Table 1: no restriction sites have been underlined.
 
Results: Design of transfection vectors: one has to go to the methodologies to see
what pCAT230p-G6 and pCAT230p-M6 are. Indicate they are modified versions of the pSIL6
vector that incorporates...
 
Figure 2. Panel 2Ai - it is hard to tell if these are rosettes or if there is just a high density of cells on
the slide.
There is no reference to figure 2ii in the text.
Figure 2 also contains figure 3 - please delete.
 
Figure 3: Panel B and C are not described in the text at all. How do these compare to blood stage
parasites? Best if they are also on the same graph. Please confirm that the mice increase in weight
after infection rather than decrease.
 
Figure 5: Again it would be best to show the oligo combinations used in the PCR beneath the figure
rather than in the figure legend for greater clarity. Panel C would be better as a scatter plot to show
variability - is the difference also significant?
 
Minor errors:
keywords - Transfection should be lower-case t.
c-terminal tagging - The c should be in capitals.
gelectrophoresis In 'Transfection' in methodology, there should be a space between gel and
electrophoresis.
Is the rationale for developing the new method (or application) clearly explained?
Yes
Is the description of the method technically sound?
Yes
Are sufficient details provided to allow replication of the method development and its use by
others?
Yes
If any results are presented, are all the source data underlying the results available to ensure full
reproducibility?
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Are the conclusions about the method and its performance adequately supported by the
findings presented in the article?
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